Get started
Author

Roberta Degli Esposti

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
2004 · E Franceschi, G Cavallo, et al. · British Journal of Cancer · 59
PDF
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma
2017 · Dario de Biase, Giovenzio Genestreti, et al. · PLoS ONE · 34
PDF
Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis
2005 · Enrico Franceschi, Giovanna Cavallo, et al. · Journal of Neuro-Oncology · 34
Primary sarcoidosis of the breast: case description and review of the literature.
2010 · R Panzacchi, C Gallo, et al. · PubMed · 26
A Randomized Controlled Trial of Tong Len Meditation Practice in Cancer Patients: Evaluation of a Distant Psychological Healing Effect
2015 · Gioacchino Pagliaro, Paolo Pandolfi, et al. · EXPLORE · 17
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
2006 · Luciano Scopece, Enrico Franceschi, et al. · Journal of Neuro-Oncology · 14
Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls
2010 · Alba A Brandes, Enrico Franceschi, et al. · Expert Review of Anticancer Therapy · 13
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005 · P F Conte, S Donati, et al. · British Journal of Cancer · 13
PDF
p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions
2010 · Dario de Biase, Luca Morandi, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 9
Cytologically Confirmed Splenic Metastases in Breast Cancer
2012 · Marco Bartolotti, Enrico Franceschi, et al. · Future Oncology · 5
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma
2017 · Giovenzio Genestreti, Dario de Biase, et al. · Clinical Lung Cancer · 4
Can OS-6 replace PFS-6 as a primary endpoint in phase II studies on glioblastoma patients given antiangiogenetic drugs?
2010 · E. Franceschi, A. A. Brandes, et al. · Journal of Clinical Oncology · 4
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
2017 · A. Musolino, F. Falcini, et al. · European Journal of Cancer · 3
PDF
Trastuzumab In Cns Progressive Metastatic Breast Cancer
2007 · Alicia Tosoni, Enrico Franceschi, et al. · Future Oncology · 1
[Prevention of oral mucositis during antiblastic chemotherapy].
1990 · L Dall'Oppio, G Gualandi, et al. · PubMed · 1
IDH mutant and 1p19q codeleted low grade gliomas: to treat or not to treat?
2017 · A. Tosoni, E. Franceschi, et al. · Annals of Oncology
The role of clinical and molecular characteristics in low grade gliomas
2017 · A. Mura, E. Franceschi, et al. · Annals of Oncology
PDF
Re-Surgery for Recurrent Glioblastoma: Outcome Analisys and Correltion with Mgmt Status
2012 · A. Brandes, E. Franceschi, et al. · Annals of Oncology
PDF
Abstract P5-12-05: 9 Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER
2010 · V Guarneri, A Frassoldati, et al. · Cancer Research
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
2004 · L. Scopece, G. Cavallo, et al. · Journal of Clinical Oncology
Evaluation of 1p and 19q chromosomal alterations in oligodendroglial neoplasms using microdissection and microsatellite analysis technique and correlations with response to chemotherapy
2004 · E. Franceschi, G. Cavallo, et al. · Journal of Clinical Oncology
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
2004 · L. Scopece, G. Cavallo, et al. · Journal of Clinical Oncology
Gemcitabine/epirubicin/paclitaxel as primary chemotherapy in stage II-IIIA operable breast cancer: final results of a multicenter Italian study
2004 · A Gennari, R Degli Esposti, et al. · European Journal of Cancer Supplements
[The clinical aspects of 4 cases of oral Kaposi's sarcoma].
1991 · M Piazzi, V Bonazzi, et al. · PubMed
Works count: 25
Citation count: 237
H-index: 9
I10-index: 8
Year
Topic
Type